Sunmax Biotechnology Co., Ltd. (TPEX:4728)

Taiwan flag Taiwan · Delayed Price · Currency is TWD
397.50
-2.50 (-0.63%)
Apr 17, 2026, 1:11 PM CST
Market Cap21.65B +22.7%
Revenue (ttm)2.03B +11.4%
Net Income725.75M +6.8%
EPS13.31 +6.8%
Shares Out54.46M
PE Ratio29.86
Forward PEn/a
Dividend12.10 (3.04%)
Ex-Dividend DateMar 31, 2026
Volume15,181
Average Volume8,209
Open398.00
Previous Close400.00
Day's Range397.00 - 398.00
52-Week Range373.00 - 501.00
Beta-0.11
RSI56.75
Earnings DateMay 12, 2026

About Sunmax Biotechnology

Sunmax Biotechnology Co., Ltd., a biomedical company, develops, manufactures, and markets biomedical grade collagen and skin care product in Taiwan and Mainland China. The company offers dermal fillers, including Sunmax Deusaderm VITAL and Sunmax Deusaderm LIDO Injectable Collagen Gel with Lidocaine. The company was founded in 2001 and is headquartered in Tainan City, Taiwan. [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2001
Country Taiwan
Stock Exchange Taipei Exchange
Ticker Symbol 4728
Full Company Profile

Financial Performance

In 2025, Sunmax Biotechnology's revenue was 2.03 billion, an increase of 11.45% compared to the previous year's 1.82 billion. Earnings were 725.75 million, an increase of 6.82%.

Financial Statements